HT
BMRN icon

HAP Trading’s BioMarin Pharmaceuticals BMRN Stock Holding History

HAP Trading’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,634
Closed -$822K – 752
2025
Q1 		$822K Sell
11,634
-2,211
-16% -$149K 0.09% 140
2024
Q4 		$910K Sell
13,845
-8,921
-39% -$598K 0.08% 141
2024
Q3 		$1.6M Sell
22,766
-12,727
-36% -$1.06M 0.18% 94
2024
Q2 		$2.92M Buy
+35,493
New +$2.95M 0.35% 54
2022
Q1 		– Sell
-19,749
Closed -$1.75M – 2239
2021
Q4 		$1.75M Buy
19,749
+3,246
+20% +$268K 0.05% 335
2021
Q3 		$1.28M Sell
16,503
-778
-5% -$61.4K 0.04% 392
2021
Q2 		$1.44M Buy
17,281
+2,600
+18% +$206K 0.05% 358
2021
Q1 		$1.11M Sell
14,681
-4,371
-23% -$357K 0.06% 298
2020
Q4 		$1.67M Sell
19,052
-3,418
-15% -$271K 0.05% 302
2020
Q3 		$1.71M Buy
+22,470
New +$2.27M 0.08% 180
2019
Q3 		– Sell
-13,739
Closed -$1.18M – 1232
2019
Q2 		$1.18M Buy
+13,739
New +$1.18M 0.09% 182
2018
Q4 		– Sell
-52,870
Closed -$5.03M – 1134
2018
Q3 		$5.13M Sell
52,870
-27,352
-34% -$2.73M 0.32% 68
2018
Q2 		$7.56M Buy
+80,222
New +$7.03M 0.38% 47
2018
Q1 		– Sell
-19,511
Closed -$1.74M – 947
2017
Q4 		$1.74M Buy
+19,511
New +$1.7M 0.07% 198
2017
Q1 		– Sell
-16,749
Closed -$1.39M – 1052
2016
Q4 		$1.39M Buy
+16,749
New +$1.44M 0.07% 201

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HAP Trading's BMRN Position: Q2 2025 in Review

HAP Trading sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2025, closing a stake of 11,634 shares — an estimated $822K sold.

HAP Trading first reported a position in BMRN in Q4 2016 and held it in 15 quarters. The position peaked at $7.56M in Q2 2018. 582 funds tracked by Wall St. Rank hold BMRN as of Q2 2025.

  • HAP Trading reported no remaining BioMarin Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • HAP Trading sold 11,634 BioMarin Pharmaceuticals shares in Q2 2025, an estimated $822K.
  • HAP Trading first reported a position in BioMarin Pharmaceuticals in Q4 2016 and held it in 15 quarters.
  • HAP Trading's BioMarin Pharmaceuticals position peaked at $7.56M in Q2 2018.
  • 582 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2025.

Based on HAP Trading's 13F filing for Q2 2025, filed 13 Aug 2025.